Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
37 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

LFCR — Lifecore Biomedical, Inc. Dilution Risk Tracker

Track LFCR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LFCR — Get alerts when the score changes →

As of August 28, 2026, Lifecore Biomedical, Inc. (LFCR) has a DilutionWatch DilutionScore of 37/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Lifecore Biomedical, Inc. has a market capitalization of $188.30M, 37.85M shares outstanding, 107 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰Cash Runway
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for LFCR.
🔔 Track LFCR — Get forecast alerts →

Market Data

Market Cap$188.30M
Shares Outstanding37.85M
Float19.62M
Cash$18.54M
Debt$111.50M
Short InterestN/A

Institutional Holdings

QoQ: ↓ 1.3% shares (2026Q1 vs prior)
107 institutional holders · 28.29M shares
#1 WYNNEFIELD CAPITAL INC 4.70M shares
#2 Legion Partners Asset Management, LLC 4.46M shares
#3 Greenhaven Road Investment Management, L.P. 3.54M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.61M
Days to Cover18.3
% of Float13.3%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-09-30
Full SEC filing analysis available with free account

Recent News

No recent news

Factual LFCR Dilution Snapshot

Lifecore Biomedical, Inc. (LFCR) has a DilutionScore of 37/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track LFCR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LFCR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for LFCR
LFCR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.